-+ 0.00%
-+ 0.00%
-+ 0.00%

ADC Therapeutics' Claudin-6 Targeting ADC Shows Strong Single-Agent And Combination Potential In Solid Tumors

Benzinga·04/28/2025 11:09:54
Listen to the news
  • Oral presentation shows ADCT-242 targeting Claudin-6 was well-tolerated and demonstrated potent antitumor activity in ovarian and non-small lung cancer
  • Poster presentations highlight antitumor activity and safety of novel PSMA-targeted and ASCT2- targeted ADCs